Until now blood stem cell mutations have primarily been associated with promoting disease progression. This is the first time that these two mutations have been shown to influence disease in different...

Study finds that interferon-alpha benefits patients with myeloproliferative neoplasms by driving mutant blood stem cells to become shorter-lived white blood cells, suggesting that more targeted treatments could reduce its significant side effects. ..

In his first week of medical school at UMass Chan, Mukund Desibhatla, MPH, attended orientation in Worcester and donated blood stem cells in Boston.

A new study shows that acquired mutations in blood stem cells—whether caused by smoking, exposure to toxins, or normal aging—interact with inherited mutations to influence a person’s lifetime risk of developing blood cancer. ...